Cargando…
Histone demethylase KDM6B inhibits breast cancer metastasis by regulating Wnt/β‐catenin signaling
Tumor metastasis remains a major challenge for patients with breast cancer. Aberrant epigenetic factor lysine‐specific demethylase 6B (KDM6B) has been associated with tumor progression. Here, we show that KDM6B is significantly down‐regulated in human breast cancer tissues, and its low expression is...
Autores principales: | Xun, Jing, Gao, Ruifang, Wang, Botao, Li, Yifan, Ma, Yuan, Guan, Jun, Zhang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329947/ https://www.ncbi.nlm.nih.gov/pubmed/34165914 http://dx.doi.org/10.1002/2211-5463.13236 |
Ejemplares similares
-
Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells
por: Romani, Massimo, et al.
Publicado: (2019) -
Substrate- and Cofactor-independent Inhibition of
Histone Demethylase KDM4C
por: Leurs, Ulrike, et al.
Publicado: (2014) -
Human histone demethylase KDM6B can catalyse sequential oxidations
por: Hopkinson, Richard J., et al.
Publicado: (2018) -
Female Bias in Rhox6 and 9 Regulation by the Histone Demethylase KDM6A
por: Berletch, Joel B., et al.
Publicado: (2013) -
Histone demethylase Kdm5c regulates osteogenesis and bone formation via PI3K/Akt/HIF1α and Wnt/β-catenin signaling pathways
por: Li, Ying, et al.
Publicado: (2023)